International Integration as Factor of Increase in Competitiveness of the Organizations of Cinematography

Integration processes in modern conditions of managing are considered as a key issue of increase in Russian film company's competitive ability at the international level. International integration allows film companies to attract additional foreign sources of financing, creates opportunities for the competition in the international market of film spectacular services, provides conditions for cooperation with the leading foreign studios and cinema companies, modernization of funding mechanisms for film projects, participation in the international film projects. Overcoming obstacles to active international cooperation of the Russian cinematographers promotes formation of film company's competitive advantages that are necessary for business on the international film market

Features of Marketing Activities on the TV-Channel in the Conditions of Eurasian Integration

The Eurasian integration processes play a significant role in the development of marketing strategy aimed at improving the competitiveness of television services on the television market through cooperation with other companies, which contributes to the formation of competitive advantages of both sides. The expansion of the interstate cooperation due to the interaction of different mass media raises the efficiency of integration processes

The Issue of Harmonization of Legislation on Public Companies in the Countries of the Integration Project “New Silk Road”

Public companies in the “New Silk Road” countries are the only effective economic entity capable, in the foreseeable future to realize the modernization of transport infrastructure, energetics and create a shared socio-cultural space in the region. Despite the fact that the concept of public enterprises varies substantially across countries of the integration project «New Silk Road» there is a common approach to solving the economic challenges that the countries of the region are facing. Political will and legislative solutions in the field of harmonization of corporate law will largely determine economic realities and political success of such a promising integration project as the «New Silk Road»

ELECTRONIC STRUCTURE OF FeSi

The full set of high-energy spectroscopy measurements including X-ray photoelectron valence band spectra and soft X-ray emission valence band spectra of both components of FeSi (Fe K_beta_5, Fe L_alpha, Si K_beta_1,3 and Si L_2,3) are performed and compared with the results of ab-initio band structure calculations using the linearized muffin-tin orbital method and linearized augmented plane wave method.Comment: 11 pages + 3 PostScript figures, RevTex3.0, to be published in J.Phys.:Cond.Matte

PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE

Aim. To pursue pharmacoeconomic analysis of two drug combinations of ACE inhibitor (enalapril) and diuretic.Material and methods. Patients with arterial hypertension degree 2 and diabetes mellitus type 2 without ischemic heart disease (n=56) were included into the study. Blood pressure (BP) dynamics and cost/effectiveness ratio were evaluated.Results. In group A (fixed combination of original enalapril/hydrochlorothiazide) 61% of patients achieved target BP level with initial dose, and the rest 39% of patients – with double dose. In group B (non-fixed combination of generic enalapril/indapamide) 60% of patients achieved the target BP with initial dose of drugs, 33% - with double dose of ACE inhibitor, and 7% - with additional amlodipine administration. In patients of group A systolic BP (SBP) reduction was 45.82±1.23 mm Hg by the 12th week vs. 40.0±0.81 mm Hg in patients of group B; diastolic BP (DBP) reduction was 22.47±1.05 mm Hg and 18.76±0.70 mm Hg, respectively, by the 12th week of treatment. In the first month of treatment costs of target BP achievement was 298.62 rubles per patient in group A, and 299.50 rubles – in group B; by the 12th week of treatment – 629.45 and 631.22 rubles, respectively. Costs of SBP and DBP reduction by 1 mm Hg during 12 weeks of therapy were 13 and 27 rubles per patient, respectively, in group A, and 16 and 34 rubles per patient, respectively, in group B.Conclusion. The original fixed combination (enalapril+hydrochlorothiazide) proved to be more clinically effective and more cost effective in the treatment of hypertensive patients in comparison with the non-fixed combination of generic drugs (enalapril+indapamide).</p

PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE

Aim. To pursue pharmacoeconomic analysis of two drug combinations of ACE inhibitor (enalapril) and diuretic.Material and methods. Patients with arterial hypertension degree 2 and diabetes mellitus type 2 without ischemic heart disease (n=56) were included into the study. Blood pressure (BP) dynamics and cost/effectiveness ratio were evaluated.Results. In group A (fixed combination of original enalapril/hydrochlorothiazide) 61% of patients achieved target BP level with initial dose, and the rest 39% of patients – with double dose. In group B (non-fixed combination of generic enalapril/indapamide) 60% of patients achieved the target BP with initial dose of drugs, 33% - with double dose of ACE inhibitor, and 7% - with additional amlodipine administration. In patients of group A systolic BP (SBP) reduction was 45.82±1.23 mm Hg by the 12th week vs. 40.0±0.81 mm Hg in patients of group B; diastolic BP (DBP) reduction was 22.47±1.05 mm Hg and 18.76±0.70 mm Hg, respectively, by the 12th week of treatment. In the first month of treatment costs of target BP achievement was 298.62 rubles per patient in group A, and 299.50 rubles – in group B; by the 12th week of treatment – 629.45 and 631.22 rubles, respectively. Costs of SBP and DBP reduction by 1 mm Hg during 12 weeks of therapy were 13 and 27 rubles per patient, respectively, in group A, and 16 and 34 rubles per patient, respectively, in group B.Conclusion. The original fixed combination (enalapril+hydrochlorothiazide) proved to be more clinically effective and more cost effective in the treatment of hypertensive patients in comparison with the non-fixed combination of generic drugs (enalapril+indapamide)

Risks and Threats of Using Open Banking in Russia and in the World

A study was conducted on the development of banking in the Russian Federation and in the countries of the world. It was determined that open banking in all countries of the world is at the stage of development. Based on literature, a comprehensive analysis of open banking functioning was conducted. Among the main problems the security risk, isolation and increased competition between banks were identified